According to IMARC Group’s latest report, titled “Regulatory Affairs Outsourcing Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026”, the global regulatory affairs outsourcing market grew at a CAGR of around 10% during 2015-2020. Regulatory affairs outsourcing is the process of hiring third-party services by the government bodies and private enterprises to ensure public health and safety. The services include managing regulatory requirements for innovator drugs, generic drugs, biologics, biosimilars, etc. The outsourcing organizations control the safety and efficacy of the medicines and ensure that they are safe for consumption. These services are required for clinical trial and patent application, product registration, legal representation, and regulatory writing and publishing. Pharmaceutical companies also opt for these services to seek speedy government approvals.
Request for a PDF
sample of this report: https://www.imarcgroup.com/regulatory-affairs-outsourcing-market/requestsample
The expanding pharmaceutical and biotechnological industries across the
globe are primarily driving the growth of the market. Furthermore, the growing
emphasis of numerous pharmaceutical organizations to enhance their operations
and supplies, particularly across the developing nations, is also augmenting
the market growth. Moreover, outsourcing of regulatory affairs also help in
reducing the costs associated with managing in-house resources, such as
facilities, technology, training, specialized knowledge and geographic
regulations. Additionally, these services are increasingly being used to
develop biosimilar and generic drugs, which is further catalyzing the market
growth. Besides this, numerous life science-based organizations are rapidly
outsourcing non-core functions and regulatory services to increase their
overall operational efficiencies, which is expected to further propel the
market in the coming years. Looking forward, IMARC Group expects the global
regulatory affairs outsourcing market to exhibit strong growth during the next
five years.
As the novel
coronavirus (COVID-19) crisis takes over the world, we are continuously
tracking the changes in the markets, as well as the industry behaviors of the
consumers globally and our estimates about the latest market trends and
forecasts are being done after considering the impact of this pandemic.
Competitive Landscape with Key Players:
·
Charles River Laboratories International Inc.
·
Covance Inc (Laboratory Corporation of America Holdings)
·
Freyr
·
ICON Plc
·
Medpace Holdings Inc.
·
Parexel International Corporation
·
Pharmaceutical Product Development LLC
·
Promedica International- A California Corporation
·
Wuxi AppTec Co. Ltd.
Market Segmentation:
Breakup
by Services:
·
Regulatory Consulting
·
Legal Representation
·
Regulatory Writing and Publishing
·
Product Registration and
Clinical Trial Applications
·
Others
Breakup by Company Size:
·
Small
·
Medium
·
Large
Breakup by Category:
·
Generic Drugs
·
Innovator Drugs
·
Biologic Drugs
·
Biosimilars
·
Medical Devices
o Therapeutic
o Diagnostic
·
Others
Breakup by Indication:
·
Oncology
·
Neurology
·
Cardiology
·
Immunology
·
Others
Breakup by Stage:
·
Preclinical
·
Clinical
·
PMA (Post Market
Authorization)
Breakup by End User:
·
Medical Device Companies
·
Pharmaceutical Companies
·
Biotechnology Companies
· North America (United States, Canada)
· Europe (Germany, France, United Kingdom, Italy,
Spain, Others)
· Asia Pacific (China, Japan, India, Australia,
Indonesia, Korea, Others)
· Latin America (Brazil, Mexico, Others)
· Middle East and Africa (United Arab Emirates, Saudi
Arabia, Qatar, Iraq, Others)
Ask
Analyst for Customization and Explore full report with TOC & List of
Figures: https://www.imarcgroup.com/regulatory-affairs-outsourcing-market
We are updating our reports, If you
want latest primary and secondary data (2021-2026) with Cost Module, Business
Strategy, Distribution Channel, etc. Click request free sample report,
published report will be delivered to you in PDF format via email within 24 to
48 hours.
Key highlights of the report:
- Market Performance (2015-2020)
- Market Outlook (2021-2026)
- Market Trends
- Market Drivers and Success Factors
- The Impact of COVID-19 on the Global Market
- Value Chain Analysis
- Structure of the Global Market
- Comprehensive mapping of the competitive landscape
If
you need specific information that is not currently within the scope of the
report, we will provide it to you as a part of the customization.
Related Reports by IMARC Group:
Europe Generic Drug Market: https://www.imarcgroup.com/europe-generic-drug-market
India Minimally Invasive Surgery Market: https://www.imarcgroup.com/india-minimally-invasive-surgery-market
Point-of-Care Diagnostics Market: https://www.imarcgroup.com/point-of-care-diagnostics-market
Negative Pressure Wound Therapy Market: https://www.imarcgroup.com/negative-pressure-wound-therapy-market
Bioinformatics Market: https://www.imarcgroup.com/bioinformatics-market
Oncology Active Pharmaceutical Ingredients
Market: https://www.imarcgroup.com/oncology-active-pharmaceutical-ingredients-market
Apheresis Equipment Market: https://www.imarcgroup.com/apheresis-equipment-market
Hospital Infection Therapeutics Market: https://www.imarcgroup.com/hospital-infection-therapeutics-market
RNA Interference Drug Delivery Market: https://www.imarcgroup.com/rna-interference-drug-delivery-market
Multiple Sclerosis Therapies Market: https://www.imarcgroup.com/multiple-sclerosis-therapies-market
Portable Medical Ventilators Market: https://www.imarcgroup.com/portable-medical-ventilators-market
IMARC’s information
products include major market, scientific, economic and technological
developments for business leaders in pharmaceutical, industrial, and high technology
organizations. Market forecasts and industry analysis for biotechnology,
advanced materials, pharmaceuticals, food and beverage, travel and tourism,
nanotechnology and novel processing methods are at the top of the company’s
expertise.
IMARC Group
30 N Gould St Ste R
Sheridan, WY 82801 USA - Wyoming
Email: Sales@imarcgroup.com
Tel No:(D) +91 120 433 0800
Americas: - +1 631 791 1145 | Africa and Europe: - +44-702-409-7331 |
Asia: +91-120-433-0800, +91-120-433-0800

No comments:
Post a Comment